Three patterns of cannabis polydrug use linked to different health risks

This Canadian study identifies three distinct patterns of simultaneous cannabis use with other drugs, revealing important public health insights as legal cannabis access expands. Researchers analyzed data from 12,344 Canadian cannabis users using latent class analysis to map how people combine cannabis with alcohol, hallucinogens, stimulants, and prescription drugs. The findings reveal a spectrum of use patterns: some users occasionally mix cannabis with alcohol, others combine it with hallucinogens, and a third group engages in high-risk polydrug use involving cannabis, alcohol, hallucinogens, illicit stimulants, and prescription medications simultaneously.

The study found that age, sex, income, and cannabis use patterns (frequency, medicinal purposes, and problematic use) were uniquely linked to which polydrug group users fell into. Crucially, different simultaneous use patterns were associated with varying levels of cannabis-related problems, suggesting that mixing cannabis with certain other substances increases health risks more significantly than others. Users in the high-risk polydrug category reported the most problems, while those with low simultaneous use experienced fewer cannabis-related harms.

These findings have immediate practical implications for public health education and harm reduction strategies in jurisdictions with legal cannabis. Understanding that cannabis users aren't a homogeneous group—but rather fall into distinct simultaneous-use patterns—can help policymakers and educators tailor targeted warnings and interventions based on specific combination risks. As cannabis legalization spreads, recognizing these usage patterns becomes essential for minimizing negative health outcomes and supporting informed decision-making among users.